NEW YORK (GenomeWeb News) — Roche has recently sold three of its 454 GS FLX sequencers to research and service organizations in Bloomington, Ind., Liverpool, UK; and Munich, Germany, according to Roche and the customers.
Â
The University of Liverpool, Indiana University, and the German companies MWG Biotech and Eurofins Medigenomix all are stocking their labs with the next-generation sequencers.
Â
Indiana’s Center for Genomics and Bioinformatics is buying a GS FLX sequencer from Roche for de novo genome sequencing, genotyping, cDNA sequencing, and microRNA sequencing, the CGB said Tuesday.
Â
The CGB, located at Indiana University Bloomington, said it paid around $500,000 for the sequencer, which it expects to install in mid-July.
Â
The IU center used a grant from the Indiana MetaCyt Initiative, which also pays for maintenance and operational costs, CGB said.
Â
The University of Liverpool, meantime, has installed a FLX in its School of Biological Sciences, making it one of only two UK universities with the new sequencer, the school said today.
Â
The school said its researchers will use the tool for projects studying marine DNA, illnesses that pass between domestic pets and humans, among other studies. Financial terms of the placement were not released.
Â
Finally, MWG Biotech and Eurofins Medigenomix upgraded to the FLX system. Last November they became the first sequencing providers in Germany to offer services on the 454 GS 20 system, the predecessor to the GS FLX.
Â
Financial terms of the placements were not released.